Evaluation of Perinatal and Developmental Outcomes in Neonates with Abstinence Syndrome Admitted to NICU
Ali Kheradmand1, Sahar Ashrafzadeh2, Farzane Rouzegari3, Samin Aliakbarian1, Ali Naseh4,*
1
Department of Psychiatry, Shahid-Beheshti University of Medical Sciences, Tehran, 19839-63113, Iran
2
David Geffen School of Medicine, University of California, Los Angeles, CA, 90095, USA
3
Shahid-Beheshti University of Medical Sciences, Tehran, 19839-63113, Iran
4
Department of Pediatrics, Clinical Research Development Center, Mahdiyeh Educational Hospital, Shahid-Beheshti University of
Medical Sciences, Tehran, 19839-63113, Iran
*
Corresponding Author: Ali Naseh. Email: a.naseh@sbmu.ac.ir; alise1349@gmail.com
International Journal of Mental Health Promotion https://doi.org/10.32604/ijmhp.2023.024773
Received 07 June 2022; Accepted 17 October 2022; Published online 06 December 2022
Abstract
Drug abuse by pregnant women is one of the significant problems for mothers and their neonates. This study
aimed to investigate the effects of maternal substance use disorder during pregnancy on neonatal developmental
criteria. In a case-control study, clinical records of 90 neonates diagnosed with neonatal abstinence syndrome who
were admitted to NICU in one of four hospitals affiliated with Shahid-Beheshti University of Medical Sciences in
Tehran, Iran between 2017 and 2020 were compared to 90 neonates without neonatal abstinence syndrome (control group). Demographic information and data for neonatal developmental characteristics and complications
were extracted from the clinical records of this convenience sample. Data for the type and method of maternal
substance use during pregnancy were collected through a telephone call with mothers. Our data showed that the
prevalence of drug addiction was 1.8% among pregnant women, and the most common drugs used by mothers
were opium (n = 45%, 50%), amphetamine (n = 30%, 33%), and methadone (n = 14%, 16%). Neonates with abstinence syndrome had a higher prevalence of transient tachypnea of the newborn (TTN) (
P = 0.004), and a prevalence of being admitted to NICU (
P = 0.05) and for a longer duration (
P < 0.001). Their mothers had a higher
prevalence of having pre-eclampsia (
P = 0.010). Using morphine vs. amphetamine showed no difference based
on their effects on mothers and neonates. Substance use during pregnancy increased the prevalence of pregnancy
complications (pre-eclampsia) and neonatal complications (TTN and prevalence and duration of hospitalization).
Therefore, planning for the development of health policies to raise awareness among women and more broadly,
all members of the community, is important to prevent the tendency to engage in this potentially high-risk
behavior.
Keywords
Drug abuse; maternal addiction; substance use disorder; neonatal abstinence syndrome; developmental characteristics; perinatal outcomes; case-control study; neonates; pregnancy